Thomas Leo Lenz, PharmD

Department

Family and Community Medicine

Position

Professor

Books

• Lenz Thomas L., Lifestyle modifications in pharmacotherapy 2012
• Lenz Thomas L., Lifestyle modifications in pharmacotherapy 2008
• Lenz Thomas L., Lifestyle modifications in pharmacotherapy 2007

Articles

• U.S. Pharmacist
  Lenz Thomas L., Implementing lifestyle medicine in hypertensive patients
  36, p. 44 - 50 2011
• Pharmacy Times
  Lenz Thomas L., Controlling diabetes
  76 2010
• U.S. Pharmacist
  Lenz Thomas L., Counseling patients about lifestyle modification
  33, p. 38 - 45 2008

Publications

• American Journal of Lifestyle Medicine
  Merlo Gia, Laying an Early Foundation
  14:5, p. 474 - 482 2020
• American Journal of Lifestyle Medicine
  White Nicole D., Using the SMART-EST Goals in Lifestyle Medicine Prescription
  14:3, p. 271 - 273 2020
• American Health and Drug Benefits
  White Nicole D., Long-term outcomes of a cardiovascular and diabetes risk- reduction program initiated by a self-insured employer
  11:4, p. 177 - 181 2018
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Drugs that Negatively Affect Sleep
  8:6, p. 383 - 385 2014
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Documenting Lifestyle Medicine Activities
  8:4, p. 242 - 243 2014
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Developing Lifestyle Medicine Tools from Psychological Theories
  8:1, p. 28 - 30 2014
• Pharmacotherapy
  Ling Hua, Reducing the Risk of Obesity: Defining the Role of Weight Loss Drugs
  33:12, p. 1308 - 1321 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Pharmacists Improving Health at the Worksite
  7:6, p. 382 - 384 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Prevalence of Medication use in Children for Cardiometabolic Risk Reduction
  7:5, p. 310 - 312 2013
• Psychology Research and Behavior Management
  White Nicole D., Tool guide for lifestyle behavior change in a cardiovascular risk reduction program
  6, p. 55 - 63 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Drug-Alcohol Interactions
  7:4, p. 250 - 252 2013
• American Journal of Lifestyle Medicine
  White N. D., Drug-Induced Photosensitivity and the Major Culprits
  7:3, p. 189 - 191 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., A Pharmacological/Physiological Comparison of Metformin and Exercise
  7:2, p. 118 - 120 2013
• ISRN preventive medicine
  Lenz Thomas L., Development of a Composite Lifestyle Index and Its Relationship to Quality of Life Improvement: The CLI Pilot Study
  2013, p. 1 - 7 2013
• The Internet journal of allied health sciences and practice
  Lenz Thomas, Finding Employees with Undiagnosed Diabetes
  11:2 2013
• Journal of the American Pharmacists Association
  White Nicole D., Comparison of cardiovascular risk calculation tools in pharmacy practice
  53:4, p. 408 - 413 2013
• Journal of Interprofessional Care
  Lenz Thomas L., Using employee experts to offer an interprofessional diabetes risk reduction program to fellow employees
  27:2, p. 197 - 199 2013
• Lenz Thomas L., Employee health 2013
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Medication use for Hypercholesterolemia in the Pediatric Population
  6:6, p. 455 - 457 2012
• American Journal of Lifestyle Medicine
  Gillespie Nicole, Resveratrol: Potential Benefits on Aging and Heart Disease
  6:5, p. 390 - 392 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., A Pharmacological/Physiological Comparison between ADHD Medications and Exercise
  6:4, p. 306 - 308 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Lessening Chemotherapy Side Effects with Lifestyle Medicine
  6:3, p. 219 - 221 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Implementing Lifestyle Medicine Guidelines into Pharmacy Practice
  6:2, p. 116 - 118 2012
• Innovations in Pharmacy
  Gillespie Nicole, Development and implementation of a novel lifestyle medicine advanced pharmacy practice experience.
  3:1, p. Article 64 (1 - 5) 2012
• Innovations in Pharmacy
  Lenz Thomas L., Lifestyle medicine related cardiovascular risk factor changes in employes participating in a pharmacist-run risk reduction program.
  3:4, p. Article 93 (1 - 8). 2012
• Pharmacotherapy
  Gillespie Nicole, Identifying employees with undiagnosed diabetes for participation in a pharmacist-run worksite wellness program.
  32:10, p. E260 - E261 2012
• Innovations in Pharmacy
  Lenz Thomas L., Health-related quality of life impact in employees participating in a pharmacist-run risk reduction program.
  3:4, p. Article 94 (1 - 8) 2012
• Innovations in pharmacy
  McKenzie Mallory C., Medication Adherence Improvements in Employees Participating in a Pharmacist-Run Risk Reduction Program
  3:4 2012
• American Journal of Lifestyle Medicine
  Gillespie Nicole D., Reducing Inflammation
  6:1, p. 21 - 23 2012
• International Journal of Pharmacy and Intergrated Life Sciences.
  Lenz TL, Blood pressure outcomes from a pharmacist-run lifestyle medicine program in an employee health setting., p. 8 - 17 2012
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Herbal Supplements for Stress
  5:6, p. 497 - 499 2011
• American Journal of Lifestyle Medicine
  Walter Andrea N., Hydration and Medication Use
  5:4, p. 332 - 335 2011
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Using Behavior Change Questionnaires to Tailor Personalized Health Communications in Pharmacy Practice
  5:2, p. 130 - 132 2011
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Myopathy in Children Receiving Chronic Corticosteroid Therapy for Asthma
  5:1, p. 44 - 46 2011
• Sports Medicine
  Lenz Thomas L., Transdermal patch drug delivery interactions with exercise
  41:3, p. 177 - 183 2011
• Advances in preventive medicine
  Gillespie Nicole D., Implementation of a Tool to Modify Behavior in a Chronic Disease Management Program
  2011, p. 215842 - 5 2011
• Journal of the American Pharmacists Association
  Lenz Thomas L., Implementing lifestyle medicine with medication therapy management services to improve patient-centered health care
  51:2, p. 184 - 188 2011
• Journal of the American Pharmacists Association
  Lenz Thomas L., Pay-for-performance model of medication therapy management in pharmacy practice
  51:3, p. 425 - 431 2011
• Journal of Obesity
  Egras Amy M., An evidence-based review of fat modifying supplemental weight loss products
  2011 2011
• Expert opinion on drug metabolism & toxicology
  Lenz Thomas L., The effects of high physical activity on pharmacokinetic drug interactions
  7:3, p. 257 - 266 2011
• Wilson Amy F., Making your pharmacy practice department 'in-dispense-able' 2011
• American journal of pharmaceutical education
  Foral Pamela A., Faculty and student expectations and perceptions of e-mail communication in a campus and distance doctor of pharmacy program.
  74:10, p. 191 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Combining Lifestyle Medicine With Medication Therapy Management Services in a Community Pharmacy Setting
  4:6, p. 484 - 487 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Medication Adherence and Its Connection With Depression and Lifestyle Medicine
  4:5, p. 413 - 415 2010
• Innovations in pharmacy
  Lenz Thomas L., A Lifestyle Medicine Clinic in a Community Pharmacy Setting
  1:1 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., The Ambulatist
  4:2, p. 134 - 137 2010
• American Journal of Pharmaceutical Education
  Packard Kathleen A., A tool to teach heart failure treatment guidelines and to assess heart failure therapy in a pharmacy cardiology rotation
  74:6, p. 1 - 7 2010
• American journal of pharmaceutical education
  Packard Kathleen A., Teaching heart failure treatment guidelines and assessing heart failure therapy
  74:6, p. 1 - 7 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Leucine With Resistance Training for the Treatment of Sarcopenia
  4:4, p. 317 - 319 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Pharmacokinetic Drug Interactions With Physical Activity
  4:3, p. 226 - 229 2010
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Pharmacodynamic Interactions with Exercise and Beta-Blocker Medications
  3:6, p. 454 - 457 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Are Physically Active Individuals Taking Statins at Increased Risk for Myopathy?
  3:4, p. 287 - 289 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Minorities and Disease Prevention in Pharmacy Practice
  3:3, p. 198 - 200 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Vitamin D Supplementation and Cancer Prevention
  3:5, p. 365 - 368 2009
• American Journal of Lifestyle Medicine
  Lenz Thomas L., Effects of Food on the Most Commonly Used Medications in School-Age Children
  3:2, p. 119 - 122 2009
• Journal of Multidisciplinary Healthcare
  Sexson Emily L., Use of a multidisciplinary tool to achieve target outcomes in native American patients with diabetes
  1, p. 73 - 77 2008
• Journal of the American Pharmacists Association
  Lenz Thomas L., Lifestyle modifications for patients with hypertension
  48:4, p. e92 - 9; quiz e100 2008
• Preventing Chronic Disease
  Lenz Thomas L., Therapeutic lifestyle strategies taught in U.S. pharmacy schools
  4:4 2007
• American journal of pharmaceutical education
  Lenz Thomas L., An elective course on lifestyle modifications in pharmacotherapy
  71:5 2007
• Journal of Interprofessional Care
  Lenz Thomas L., An interprofessional medication risk assessment program
  20:5, p. 558 - 560 2006
• Journal of Pharmacy Teaching
  Lenz Thomas L., Assessing the use of two-way interactive video (TWIV) conferencing to offer heart failure continuing education to rural pharmacists
  13:1, p. 29 - 36 2006
• Journal of Pharmacy Teaching
  Lenz Thomas L., Instructor workload of a campus-based versus a web-based pharmacy course
  12:2, p. 97 - 106 2006
• International journal of chronic obstructive pulmonary disease
  Faulkner Michele A., Cost-effectiveness of smoking cessation and the implications for COPD.
  1:3, p. 279 - 287 2006
• American journal of pharmaceutical education
  Lenz Thomas L., Using performance-based assessments to evaluate parity between a campus and distance education pathway
  70:4, p. 1 - 6 2006
• HeartDrug
  Lenz Thomas L., Nesiritide usage in decompensated heart failure
  5:2, p. 81 - 88 2005
• Consultant Pharmacist
  Faulkner Michele A., Osteoporosis in long-term care residents with multiple sclerosis
  20:2, p. 128 - 136 2005
• Expert Review of Pharmacoeconomics and Outcomes Research
  Hunter Claire B., Nesiritide for heart failure
  5:1, p. 15 - 21 2005
• Journal of the American Pharmacists Association
  Lenz Thomas L., Lifestyle modification counseling of patients with dyslipidemias by pharmacists and other health professionals
  45:6, p. 709 - 713 2005
• Journal of the American Pharmacists Association
  Lenz Thomas L., Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemias in adults
  45:4, p. 492 - 502 2005
• American journal of pharmaceutical education
  Lenz Thomas L., Faculty workload comparison between a campus-based and internet-based patient assessment course
  69:4, p. 495 - 499 2005
• American Heart Journal
  Mooss Aryan N., Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: The Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial
  148:4, p. 641 - 648 2004
• Pharmacotherapy
  Lenz Thomas L., Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failure
  24:9, p. 1137 - 1146 2004
• Journal of the American Pharmacists Association
  Lenz Thomas L., Supplemental products used for weight loss
  44:1, p. 59 - 68 2004
• Sports Medicine
  Lenz Thomas L., Potential interactions between exercise and drug therapy
  34:5, p. 293 - 306 2004
• Advances in Pharmacy
  Lenz Thomas L., Rosuvastatin: A new HMG-CoA reductase inhibitor for the treatment of dyslipidemia
  2, p. 136 - 145 2004
• Journal of cardiac failure
  Lenz Thomas L., Impact of nesiritide on complications and health-care resources in decompensated heart failure
  9:5, p. S66 - S66 2003
• Annals of Pharmacotherapy
  Faulkner Michele A., Gabapentin for the treatment of tremor
  37:2, p. 282 - 286 2003
• Clinical Pharmacokinetics
  Lenz Thomas L., Clinical pharmacokinetics of antiplatelet agents used in the secondary prevention of stroke
  42:10, p. 909 - 920 2003
• Pharmacotherapy
  Packard Kathleen A., Comparison of gemfibrozil and fenofibrate in patients with dyslipidemic coronary heart disease
  22:12 I, p. 1527 - 1532 2002
• Chest
  Wurdeman Richard L., Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery
  121:4, p. 1203 - 1210 2002
• ASHP Midyear Clinical Meeting
  Hilleman Daniel E., Comparison of gemfibrozil and fenofibrate in hyperlipidemic coronary heart disease patients
  36, p. P - E 2001
• American journal of hypertension
  Hilleman Daniel E., P-250: Cost-effectiveness evaluation of fixed-dose combination of angiotensin-II receptor blockers with and without hydrochlorothiazide
  14:S1, p. 112A - 113A 2001
• Pharmacotherapy
  Hilleman Daniel E., Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease
  21:4, p. 410 - 415 2001
• Pharmacotherapy
  Lenz T. L., Comparison of 24-hour blood pressure profiles in patients with hypertension who were switched from amlodipine to nisoldipine
  21:8, p. 898 - 903 2001
• P and T
  Lenz T. L., The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease
  26:11, p. 561 - 562+565 2001
• Drugs of Today
  Lenz T. L., Dofetilide
  36:11, p. 759 - 771 2000
• Chest
  Wurdeman Richard L, COMPARATIVE ANTIARRHYTHMIC EFFECTS OF PROPHYLACTIC AMIODARONE VERSUS SOTALOL BY META-ANALYSIS FOLLOWING CARDIAC SURGERY
  118:4, p. 108 2000
• Annals of Pharmacotherapy
  Lenz Thomas L., Aggrenox
  34:11, p. 1283 - 1290 2000
• Pharmacotherapy
  Lenz Thomas L., Dofetilide, a new class III antiarrhythmic agent
  20:7 I, p. 776 - 786 2000
• Chest
  Scott Walter J, SMOKING CESSATION TREATMENT STRATEGIES FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY
  116:4, p. 286 1999
• Chest
  Hilleman Daniel E, RATE CONTROL IN POST-CABG ATRIAL FIBRILLATION: A COMPARISON OF BETA-BLOCKER VERSUS CALCIUM ANTAGONIST WITH AND WITHOUT DIGOXIN
  116:4, p. 282 1999

Presentations

• Dr. Tom Lenz: Panel Discussion. Sustainable Strategies to Support Well-Being for Healthcare Professionals. Presented at the Midwest Chapter of the American College of Healthcare Executives. April 24, 2024. Omaha, NE 2024
• Dr. Tom Lenz: HW Application in Chronic Disease. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference 2024
• Dr. Tom Lenz: Connection, Compassion, Contemplation: Guiding Principles Toward Well-Being and Improved Mental Health. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference. (invited) 2024
• Dr. Tom Lenz: Chronic Stress as a Pathway to Chronic Disease. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference. 2024
• Dr. Tom Lenz: Sleep as Medicine. Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference 2024
• Dr. Tom Lenz: What is Integrative Health and Wellness? Presented at 2024 Primary Care Update Preconference: Integrative Health and Wellness. April 4, 2024. Omaha, NE. Podium and Teleconference 2024
• 2023
• Dr. Tom Lenz pesented: Connection, Compassion, Contemplation. Guiding Principles Toward Well-Being. Presented at Leadership Retreat for CHI/Mercy Hospital. April 26, 2023. Council Bluffs, Iowa. (Invited) 2023
• Dr. Tom Lenz pesented: Connection, Compassion, Contemplation. Guiding Principles Toward Well-Being. Presented at Leadership Retreat for CHI/Immanuel Medical Center. April 14, 2023. Omaha, Nebraska. (Invited) 2023
• Lifestyle Medicine. Presented to the faculty and students in the School of Pharmacy and Health Professions at Creighton University. March 25, 2014. (invited) 2014
• Creating a Personal Teaching Philosophy Statement. Department of Pharmacy Practice, Creighton University. December 18, 2013. Omaha, Nebraska 2013
• Be Your Own First Patient. Presented at the Nebraska Department of Health and Human Services Conference on Creating a Culture of Wellness in Healthcare Settings. May 18, 2013. Nebraska City, NE. (invited) (presented with Nicole White, PharmD) 2013
• Lifestyle Medicine in Pain Management. Presented at: TOGETHER. Providing Quality Care to Pain Patients in Iowa. A Multidisciplinary Conference. February 8, 2013. Des Moines, Iowa. (Invited) 2013
• Cardiovascular and Diabetes Risk Reduction Program Outcomes. Presented to the Creighton University Wellness Council. November 8, 2012. Omaha, Nebraska. (Invited) 2012
• Optimizing Your Pharmacy Distance Pathway Educational Mentor. Presented to the Creighton University Pharmacy Program Faculty. October 23, 2012. Omaha, Nebraska. 2012
• The Ambulatist: A Novel Employee Health Specialty Position. American College of Preventive Medicine 2012 Annual Meeting. February 23, 2012. Orlando, FL 2012
• Implementing Lifestyle Medicine with Clinical Pharmacy Practice. Presented to the Midwest College of Clinical Pharmacy. November 29, 2011. Omaha, Nebraska. (Invited) 2011

Awards

• Nomination - S.J. Diversity Award for Excellence & Innovation
  2015 John P. Schlegel, S.J. Diversity Award for Excellence & Innovation
• Certificate of Recognition
  Strategic Plan Initiatives, Creighton University
• Excellence in Innovation
  Nebraska Pharmacists Association

Consulting

• Faculty Associate - Office of Interprofessional Scholarship, Service, and Education, Creighton University School of Pharmacy and Health Professions
  2006 - 2006
• Consultant - Creighton University Athletic Department
  2000 - 2000